VTV Therapeutics Inc. Class AVTVT
13F holders, Q4 2025 (December 31)27holders +4
6new positions
3sold out
$39.99avg. 13F price*
At the end of Q4 2025, 27 institutions reported holding VTV Therapeutics Inc. Class A (VTVT) in their 13F filings, up 4 from Q3 2025. 6 opened new positions and 3 sold out. The largest holders were Samsara Biocapital, LLC ($11.9M), FMR LLC ($10.8M) and Trails Edge Capital Partners, LP ($9.2M).
- Company
- VTV Therapeutics Inc. Class A
- CUSIP
- 918385204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $1.3M |
| Exits | 3 | $532K |
All 13F filers, Q3 2025 → Q4 2025: 164,930 shares bought and 100,587 shares sold, net +64,343 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 27 holders
| Samsara Biocapital, LLC | 1.23% | Reduce -20.3% | 298,496 | $11.9M |
| FMR LLC | 0.00% | Add +39.4% | 268,856 | $10.8M |
| Trails Edge Capital Partners, LP | 2.28% | — | 231,000 | $9.2M |
| Siren, L.L.C. | 0.19% | No change | 163,000 | $6.5M |
| Baker Bros. Advisors LP | 0.03% | No change | 148,314 | $5.9M |
| Vanguard Group Inc. | 0.00% | Add +77.5% | 83,400 | $3.3M |
| Geode Capital Management, LLC | 0.00% | Add +84.3% | 28,194 | $1.1M |
| 683 Capital Management, LLC | 0.06% | New | 18,268 | $731K |
| Northern Trust Corp. | 0.00% | Add +14.1% | 16,052 | $642K |
| BlackRock, Inc. | 0.00% | Add +114.9% | 10,606 | $424K |
| Pathstone Holdings, LLC | 0.00% | New | 6,073 | $243K |
| Goldman Sachs Group Inc. | 0.00% | New | 5,531 | $221K |
| UBS Group AG | 0.00% | Reduce -43.8% | 1,668 | $67K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 1,268 | $51K |
| Osaic Holdings, Inc. | 0.00% | Reduce -30.9% | 1,120 | $45K |
| Morgan Stanley | 0.00% | Add +31.0% | 977 | $39K |
| Farther Finance Advisors, LLC | 0.00% | New | 279 | $11K |
| Citigroup Inc. | 0.00% | Add +24300.0% | 244 | $10K |
| Bessemer Group Inc. | 0.00% | New | 112 | $4K |
| Activest Wealth Management | 0.00% | No change | 50 | $2K |
| CoreCap Advisors, LLC | 0.00% | No change | 45 | $2K |
| Parallel Advisors, LLC | 0.00% | No change | 38 | $2K |
| Sunbelt Securities, Inc. | 0.00% | No change | 15 | $600 |
| BNP Paribas Financial Markets | 0.00% | No change | 9 | $360 |
| Bank of America Corp. | 0.00% | Add +300.0% | 4 | $160 |
| SBI Securities Co., Ltd. | 0.00% | No change | 2 | $80 |
| Strategic Wealth Partners, Ltd. | 0.00% | No change | 1 | $40 |
"% of holder's portfolio" is VTVT's weight in each manager's 13F, not the share of VTV Therapeutics Inc. Class A the manager owns.